http://www.gilead.com
Gilead Sciences, Inc. Company Intro
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Industry
Healthcare
Gilead Sciences, Inc. Headquaters
333 Lakeside Drive
Foster City,94404
United States
Gilead Sciences, Inc. Share price
15 Jan 2021 01:43 GMT
$61.64
0.1 (0.16 %)
Gilead Sciences, Inc. Market cap
$78.22 B
WMC RANKING
2021
Gilead Sciences, Inc. # 10
Drug Manufacturers—GeneralLatest Gilead Sciences, Inc. News
17 Jan 2021
Sickle Cell Disease Treatment Market Study by Verified ...
Pfizer Inc. • Eli Lilly • Merck & Co Inc • Novartis AG • Sanofi • Baxter • Bristol-Myers Squibb Company • Bluebird ...
17 Jan 2021
Comprehensive Report on Choroidal Neovascularization Market 2021 | Trends, Growth Demand, Opportunities & ...
Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron ... Ltd., Promedior Inc., Valeant Pharmaceuticals International Inc., Gilead Sciences Inc. The key ...
17 Jan 2021
Agenus Inc. - Consensus Indicates Potential 133.9% Upside
... with Gilead Sciences to develop immuno-oncology therapies. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in ...
WMC Market Score
WMC Market to Revenue Score
Gilead Sciences, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Gilead Sciences, Inc. | USD | $23,147,000 | $15,777,000 | $1,268,000 | $782,200B | 10 |
| Johnson & Johnson | USD | $80,856,000 | $33,169,000 | $16,986,000 | $4,229,180B | 1 |
| Pfizer Inc. | USD | $48,649,000 | $25,918,000 | $8,685,000 | $2,042,710B | 2 |
| Merck & Co., Inc. | USD | $47,347,000 | $20,541,000 | $11,517,000 | $2,078,930B | 3 |
| GlaxoSmithKline plc | GBP | £34,259,000 | £14,523,000 | £6,371,000 | £700,880B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Gilead Sciences, Inc. Social Followers vs Top 4 Industry Competitors
Gilead Sciences, Inc. Post vs Top 4 Industry Competitors
Gilead Sciences, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Gilead Sciences, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Gilead Sciences, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Gilead Sciences, Inc. | 28.63 | 2.04 | 7.73 | 0 | 0 | 0 | 3.31 |
| Johnson & Johnson | 100 | 100 | 100 | 100 | 0 | 0 | 100 |
| Pfizer Inc. | 60.17 | 48.12 | 51.03 | 1 | 0 | 0 | 33.29 |
| Merck & Co., Inc. | 58.56 | 21.02 | 92.27 | 0 | 0 | 0 | 37.78 |
| GlaxoSmithKline plc | 57.76 | 25.90 | 87.11 | 1 | 0 | 0 | 38.10 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
